KalVista Pharmaceuticals (KALV)

KalVista Pharmaceuticals Limited • KalVista Securities Holding Corporation • KalVista Pharmaceuticals (Ireland) Limited • KalVista Pharmaceuticals CH GmbH • KalVista Pharmaceuticals Japan K.K. ...

KALV stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Average target

$28.50

Low target

$22.00

High target

$35.00

Latest filings (excl ownership)

View all

8-K

KalVista Appoints Jeb Ledell as Chief Operating Officer

16 Dec 24

8-K

KalVista Pharmaceuticals Reports Second Fiscal Quarter Results and Provides Operational Update

5 Dec 24

KalVista Pharmaceuticals Appoints Laurence Reid, Ph.D., to Board of Directors

26 Nov 24

8-K

KalVista Pharmaceuticals Announces Pricing of a $55 Million Underwritten Offering of Common Stock and Concurrent Private Placement of $5 Million

4 Nov 24

424B5

Prospectus supplement for primary offering

4 Nov 24

8-K

Entry into a Material Definitive Agreement

4 Nov 24

8-K

Submission of Matters to a Vote of Security Holders

4 Oct 24

8-K

KalVista Appoints Brian Piekos as Chief Financial Officer

10 Sep 24

8-K

KalVista Pharmaceuticals Reports First Fiscal Quarter Results and Provides Operational Update

5 Sep 24

Latest ownership filings

View all

TANG CAPITAL MANAGEMENT LLC

14 Nov 24

SC 13G/A

SUVRETTA CAPITAL MANAGEMENT, LLC

14 Nov 24

Financial summary

Financial statements Chart KALV financial data

Quarter (USD)	Oct 24	Jul 24	Apr 24	Jan 24
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Apr 24	Apr 23	Apr 22	Apr 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	41.58 mm	41.58 mm	41.58 mm	41.58 mm	41.58 mm	41.58 mm
Cash burn (monthly)	(no burn)	1.34 mm	15.27 mm	14.30 mm	13.21 mm	10.21 mm
Cash used (since last report)	n/a	2.37 mm	26.99 mm	25.28 mm	23.36 mm	18.05 mm
Cash remaining	n/a	39.21 mm	14.59 mm	16.30 mm	18.22 mm	23.53 mm
Runway (months of cash)	n/a	29.3	1.0	1.1	1.4	2.3

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q2 2024

KALV institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	78	114	-31.6%
Opened positions	26	50	-48.0%
Closed positions	62	13	+376.9%
Increased positions	18	22	-18.2%
Reduced positions	18	23	-21.7%

13F shares	Current	Prev Q	Change
Total value	388.24 bn	321.01 bn	+20.9%
Total shares	49.07 mm	43.47 mm	+12.9%
Total puts	26.30 k	41.90 k	-37.2%
Total calls	21.80 k	47.50 k	-54.1%
Total put/call ratio	1.2	0.9	+36.8%

Largest owners	Shares	Value	Change
VR Adviser	6.25 mm	$73.62 bn	NEW
Venrock Healthcare Capital Partners III	4.82 mm	$0.00	0.0%
Tang Capital Management	4.22 mm	$49.70 bn	NEW
Suvretta Capital Management	4.19 mm	$49.38 bn	NEW
Frazier Life Sciences Management	3.69 mm	$43.44 bn	0.0%
Tang Capital Partners	3.20 mm	$0.00	0.0%
Vestal Point Capital	2.30 mm	$27.09 bn	NEW
Adage Capital Partners GP, L.L.C.	2.05 mm	$24.15 bn	-20.4%
Venrock Healthcare Capital Partners II	2.04 mm	$34.59 mm	0.0%
Boxer Capital	1.59 mm	$18.73 bn	0.0%

Largest transactions	Shares	Bought/sold	Change
VR Adviser	6.25 mm	+6.25 mm	NEW
Tang Capital Management	4.22 mm	+4.22 mm	NEW
Suvretta Capital Management	4.19 mm	+4.19 mm	NEW
BLK BlackRock	0.00	-2.43 mm	EXIT
Vestal Point Capital	2.30 mm	+2.30 mm	NEW
Vanguard	0.00	-1.69 mm	EXIT
Capital World Investors	0.00	-1.46 mm	EXIT
Great Point Partners	1.34 mm	+1.34 mm	NEW
First Turn Management	0.00	-1.18 mm	EXIT
TCG Crossover Management	0.00	-1.16 mm	EXIT

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

KALV insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
9 Dec 24	Benjamin L Palleiko	Common Stock	Sell	Dispose S	No	No	9.75	7,627	74.36 k	274,596
6 Dec 24	Benjamin L Palleiko	Common Stock	Option exercise	Acquire M	No	No	0	15,625	0.00	282,223
6 Dec 24	Benjamin L Palleiko	RSU Common Stock	Option exercise	Dispose M	No	No	0	15,625	0.00	203,126
26 Nov 24	Christopher Yea	Common Stock	Sell	Dispose S	No	No	9.8718	1,963	19.38 k	91,142
26 Nov 24	Paul K. Audhya	Common Stock	Sell	Dispose S	No	No	9.8702	2,187	21.59 k	97,012
23 Nov 24	Laurence Reid	Stock Option Common Stock	Grant	Acquire A	No	No	10.07	17,000	171.19 k	17,000
22 Nov 24	Christopher Yea	Common Stock	Option exercise	Acquire M	No	No	0	3,125	0.00	93,105
22 Nov 24	Christopher Yea	RSU Common Stock	Option exercise	Dispose M	No	No	0	3,125	0.00	43,750
22 Nov 24	Paul K. Audhya	Common Stock	Option exercise	Acquire M	No	No	0	5,000	0.00	99,199
22 Nov 24	Paul K. Audhya	RSU Common Stock	Option exercise	Dispose M	No	No	0	5,000	0.00	70,000